Please note that our laboratory will be closed for an extended weekend due to the public holiday on 09.05.2024! Please only send samples that reach our laboratory by Wednesday, 08.05.24. Samples will not be accepted at the weekend. From 13.05.24 we will be there for you again as usual.
According to Fatigatio e.V., the determination of autoantibodies against ß1 and ß2 adrenergic receptors, as well as against M3 and M4 acetylcholine receptors can round off the diagnostic process to ME/CFS. Together with Prof. Dr. Carmen Scheibenbogen (Charité), CellTrend developed and validated this test system. For more information, please have a look at: this site!
In 2018, James P. Allison and Tasuku Honjo received the Nobel Prize in Medicine for the discovery of a tumor therapy through negative immune regulation. Here, the binding between PD1 (Programmed cell death protein 1) and PD-L1 (Programmed cell death protein 1 ligand) is inhibited. CellTrend has discovered autoantibodies against PD1 and PD-L1 in tumor…
On January 10, 2024, Member of the Bundestag Sylvia Lehmann (direct mandate of the constituency) visited CellTrend and was informed about autoantibody diagnostics.
